Equifax (EFX) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Equifax Inc. (EFX) insider buying and selling: 1 purchase, 13 sales
69 Form 4 Table I transactions filed with the SEC by Equifax Inc. insiders between 2025-10-28 and 2026-09-08 (15-month history): 1 open-market purchase and 13 sales, plus 55 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $11.4M by Begor Mark W on 2025-10-27.
Equifax insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Equifax insiders filed 1 purchase worth $465k and 13 sales worth $38.5M on the open market. The net balance is on the sell side: $38.0M more sold than bought.
The biggest buyer was Mao Cecilia (EVP, Chief Product Officer): $465k in 1 purchase, the only buyer. The biggest seller was Begor Mark W (CEO): $32.1M in 4 sales, out of 4 different sellers.
The largest trade of the period was a sale of $11.4M on Oct 27, 2025, by Begor Mark W (CEO), under a 10b5-1 plan. Form 4 on sec.gov (0001225208-25-008793).
All 13 sales carry the 10b5-1 plan flag on the Form 4: scheduled months ahead. The only purchase was also scheduled under a 10b5-1 plan.
The last three months show 0 purchases and 2 sales, against 0 and 3 in the three before. The latest purchase is from Feb 18, 2026; the latest sale from Sep 3, 2026.
Against its sector (Industrials, 75 companies with an insider page on this site), over the same dates the median is 8 sales and 0 purchases on the open market. Equifax has more sales than 50 of the other 74, ranks 21 of 75 by net dollars sold, and 28 of the 75 have at least one purchase, Equifax included.
The 20 most important trades
The only open-market purchase first, then the rest, each type from largest to smallest. The full history is in the tool above, already searched.
See all 69 EFX trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-19 | Mao Cecilia | EVP, Chief Product Officer | $465k | P — Open-market purchase (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/18/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2025-10-27 | 2025-10-29 | Begor Mark W | CEO | $11.4M | S — Open-market sale (scheduled 10b5-1) Indirect holding, through: 2-yr Jun 2025 GRAT 15 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.795 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $234.93 to $235.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.74 to $231.734, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.74 to $233.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F8 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.74 to $230.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F9 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.735 to $232.71, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F10 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.88 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F11 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.85 to $233.80, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F12 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.83 to $231.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F13 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.685, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F14 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.845 to $232.81, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F15 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.7507 to $230.7266, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. | SEC |
| 2026-02-10 | 2026-02-12 | Begor Mark W | CEO | $7.6M | S — Open-market sale (scheduled 10b5-1)13 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.524 to $198.008, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $203.675 to $203.85, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $192.556 to $193.366, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $193.735 to $194.661, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $194.892 to $195.779, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F8 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.123 to $196.912, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F9 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.645 to $199.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F10 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.67 to $200.481, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F11 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.672 to $201.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F12 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $202.665 to $203.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F13 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $201.67 to $202.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. | SEC |
| 2026-04-24 | 2026-04-28 | Begor Mark W | CEO | $6.5M | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $173.98 to $174.78, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 280 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $172.986 to $173.975, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $170.982 to $171.979, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $171.986 to $172.975, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. | SEC |
| 2026-07-24 | 2026-07-28 | Begor Mark W | CEO | $6.5M | S — Open-market sale (scheduled 10b5-1)10 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $175.74 to $175.94, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $169.42 to $170.09, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $168.395 to $168.55, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $174.54 to $175.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $173.50 to $174.15, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F8 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $172.50 to $173.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F9 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $170.48 to $171.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F10 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $171.50 to $172.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. | SEC |
| 2026-02-10 | 2026-02-12 | Farshchi Jamil | EVP, Chief Technology Officer | $1.2M | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
| 2025-10-27 | 2025-10-28 | Farshchi Jamil | EVP, Chief Technology Officer | $1.2M | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 372 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
| 2026-02-23 | 2026-02-25 | Gamble John W Jr | EVP, CFO & COO | $881k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2026-09-03 | 2026-09-08 | Gamble John W Jr | EVP, CFO & COO | $846k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2026. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2026-05-01 | 2026-05-05 | Gamble John W Jr | EVP, CFO & COO | $618k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2025-11-20 | 2025-11-21 | Gamble John W Jr | EVP, CFO & COO | $521k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2026-02-12 | 2026-02-17 | Borton Chad M | EVP, Pres Workforce Solutions | $485k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/4/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2026-05-07 | 2026-05-08 | Borton Chad M | EVP, Pres Workforce Solutions | $427k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/4/2025. F1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2026-02-11 | 2026-02-12 | Farshchi Jamil | EVP, Chief Technology Officer | $233k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
| 2025-10-27 | 2025-10-29 | Begor Mark W | CEO | $5.4M | M — Option exercise (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
| 2026-07-24 | 2026-07-28 | Begor Mark W | CEO | $4.2M | M — Option exercise (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
| 2026-04-24 | 2026-04-28 | Begor Mark W | CEO | $4.2M | M — Option exercise (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 280 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
| 2026-02-10 | 2026-02-12 | Begor Mark W | CEO | $4.2M | M — Option exercise (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
| 2026-02-10 | 2026-02-12 | Gamble John W Jr | EVP, CFO & COO | $1.4M | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. | SEC |
| 2026-02-10 | 2026-02-12 | Farshchi Jamil | EVP, Chief Technology Officer | $1.2M | M — Option exercise (scheduled 10b5-1)2 Form 4 footnotesF1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. | SEC |
The period balance: money in, money out
Across the Form 4 filings submitted between Oct 28, 2025 and Sep 8, 2026, Equifax Inc. open-market activity adds up to 1 purchase worth $465k and 13 sales worth $38.5M. The net balance is $38.0M on the sell side.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Equifax Inc.'s is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 31 | $2.0M |
| F | Tax withholding (shares surrendered for taxes) | 17 | $5.5M |
| S | Open-market sale | 13 | $38.5M |
| M | Option exercise | 6 | $20.2M |
| G | Gift | 1 | $0 |
| P | Open-market purchase | 1 | $465k |
| Total | Everything filed in the period | 69 | $66.6M |
23 of the 69 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 22 distinct people or entities have filed Equifax Inc. transactions: 1 bought on the open market and 4 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Begor Mark W | CEO | 15 | — | $32.1M (4) | 2026-07-28 |
| Gamble John W Jr | EVP, CFO & COO | 8 | — | $2.9M (4) | 2026-09-08 |
| Farshchi Jamil | EVP, Chief Technology Officer | 8 | — | $2.6M (3) | 2026-02-27 |
| Borton Chad M | EVP, Pres Workforce Solutions | 4 | — | $912k (2) | 2026-05-08 |
| Mao Cecilia | EVP, Chief Product Officer | 4 | $465k (1) | — | 2026-02-27 |
| Chaney Carla | EVP, Chief HR Officer | 4 | — | — | 2026-02-27 |
| Houston Julia A | EVP, Chief Legal Officer | 4 | — | — | 2026-02-27 |
| Bindal Sunil | EVP, Chief Corp Dev Officer | 3 | — | — | 2026-02-27 |
Shown here are the 8 who moved the most money, out of 22. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Feb 2026: 1 purchase and 5 sales, worth $10.9M. 8 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 0 | $0 |
| Oct 2025 | 0 | $0 | 2 | $12.6M |
| Nov 2025 | 0 | $0 | 1 | $521k |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 1 | $465k | 5 | $10.4M |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 1 | $6.5M |
| May 2026 | 0 | $0 | 2 | $1.0M |
| Jun 2026 | 0 | $0 | 0 | $0 |
| Jul 2026 | 0 | $0 | 1 | $6.5M |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 1 | $846k |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Equifax Inc. (EFX) analysis page →
Other Industrials companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
13 of the 13 sales in the table are flagged as scheduled (10b5-1 plan): signed months ahead and executed automatically, so they say nothing about what the insider thinks today. Equifax's single open-market purchase (code P) is the rare signal: insiders are already paid in stock, so buying more means putting in their own money. The latest filing is from Sep 8, 2026, and a Form 4 arrives up to two business days after the trade.
20 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.